We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Shenzhen New Industries Biomedical Engineering Co., Ltd. (SNIBE)

Shenzhen New Industries Biomedical Engineering Co., Ltd. (SNIBE) is a biotechnology company specializing in clinical ... read more Featured Products: More products

Download Mobile App




New biochemistry analyzer helps labs realize full automation and maximum efficiency

By LabMedica International staff writers
Posted on 26 May 2022
Print article
Image: Biossays C8 automatic biochemistry analyzer (Photo courtesy of SNIBE)
Image: Biossays C8 automatic biochemistry analyzer (Photo courtesy of SNIBE)

Snibe (Shenzhen, China) has launched the new Biossays C8 automatic biochemistry analyzer, marking the beginning of a new journey in clinical chemistry management. Its powerful performance and modular scalability enables labs to realize full automation and maximum efficiency.

The Biossays C8 automatic biochemistry analyzer has a high throughput of 1600 tests per hour (single module) and 6400 tests per hour (four modules combined). It has two reagent compartments with 72 positions each and a total of 300 sample positions. The precise control of temperature and voltage of light source lamp guarantee minor fluctuation of the light source and long life of the lamp. It has a configurable decapper module that can improve lab efficiency with no manual operation required of the sample tubes. It allows for full mixing with adjustable speed and the mixing speed of different reagents can be set independently.

The Biossays C8 also enables complete washing with less wash liquid required, automatic selection of acid and alkali liquid (assay dependent) and double washing of each mixing bar. The ISE module for five common ions is also configurable according to individual needs. The Biossays C8 can be linked with Laboratory Automation system (TLA/LAS) and create a random combination within four units according to testing demand. It is capable of integrating the immunoassay analyze MAGLUMI X8, which perfectly realizes the function of TLA but only takes up a small space in the lab.

Related Links:
Snibe

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS

Print article

Channels

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.